|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Retrospective Clinical Study |
Department of Neurology (T.G.P., B.P.O.) and the Division of Hematopathology (P.J.K.), Mayo Clinic and Mayo Foundation, Rochester, MN 55905
2 Address correspondence and reprint requests to Brian P. O'Neill, Department of Neurology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.
Abstract
The records and neuro-imaging studies of 8 cases of post-transplant primary CNS lymphoma (PT-PCNSL) diagnosed at Mayo Clinic Rochester between 1970 and 1998 were reviewed retrospectively. All patients received organ transplantation. Patients who had hematologic transplantation were not included in the analysis. The median and mean age of the 4 men and 4 women was 45 years (range, 34 to 50 years). The median duration of symptoms before diagnosis was 36 days (range, 5 to 98 days). At diagnosis, the neurologic examination was focally abnormal in 6 of 8 patients. Compared with the initial computed tomographic study, MRI showed 25 additional brain lesions. Only 43.7% of lesions enhanced with contrast agent; of those that did, all but one were heterogeneous. Ependymal contact occurred in 5 patients. MRI lesion burden increased proportionally to the interval between scans. Diagnostic tissue was obtained by stereotactic biopsy from 6 patients and by open biopsy from 2. Hemorrhage occurred in the biopsy area in 4 patients who had stereotactic biopsy and 2 died (all had normal coagulation studies). Slides available for review (7 patients) showed that the tumors were of CD20-positive lineage and were positive for Epstein-Barr virus, using in situ hybridization. Six patients died. Median survival for the cohort was 13 weeks. PT-PCNSL has clinical and imaging features distinct from typical PCNSL. In our series, (1) PT-PCNSL presented nonspecifically and progressed rapidly, (2) stereotactic brain biopsy had significant morbidity, and (3) despite multimodal therapy, survival was poor.
References
Alderson, L., Fetell, M.R., Sisti, M., Hochberg, F., Cohen, M., and
Louis, D.N. (1996) Sentinel lesions of primary CNS lymphoma.
J. Neurol. Neurosurg. Psychiatry
60,102
-105.
Arcasoy, S.M., and Kotloff, R.M. (1999) Lung
transplantation. N. Engl. J. Med.
340,1081
-1091.
Aris, R.M., Maia, D.M., Neuringer, I.P., Gott, K., Kiley, S., Gertis, K., and Handy, J. (1996) Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient. Am. J. Respir. Crit. Care Med. 154,1712 -1717.[Abstract]
Balmaceda, C., Gaynor, J.J., Sun, M., Gluck, J.T., and DeAngelis, L.M. (1995) Leptomeningeal tumor in primary central nervous system lymphoma: Recognition, significance, and implications. Ann. Neurol. 38,202 -209.[CrossRef][ISI][Medline]
Barnett, L.B., and Schwartz, E. (1974) Cerebral
reticulum cell sarcoma after multiple renal transplants. J. Neurol.
Neurosurg. Psychiatry 37,966
-970.
Bender, G.P., and Schapiro, R.T. (1989) Primary CNS lymphoma presenting as multiple sclerosis: A case study. Minn. Med. 72,157 -160.[ISI][Medline]
Brecher, K., Hochberg, F.H., Louis, D.N., de la Monte, S., and
Riskind, P. (1998) Case report of unusual
leukoencephalopathypreceding primary CNS lymphoma. J. Neurol.
Neurosurg. Psychiatry 65,917
-920.
Brink, N.S., Sharvell, Y., Howard, M.R., Fox, J.D., Harrison, M.J.,
and Miller, R.F. (1998) Detection of Epstein-Barr virus and
Kaposi's sarcoma-associated herpesvirus: DNA in CSF from persons infected with
HIV who had neurological disease. J. Neurol. Neurosurg.
Psychiatry 65,191
-195.
Ciancio, G., Siquijor, A.P., Burke, G.W., Roth, D., Cirocco, R., Esquenazi, V., Byrne, G.E., Jr., and Miller, J. (1997) Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. Clin. Transplant. 11,243 -249.[ISI][Medline]
Claviez, A., Neubauer, B., Link, J., and Schneppenheim, R. (1998) Intracerebral hemorrhage as a late complication after CNS treatment of childhood lymphoma. Klin. Padiatr. 210,406 -408.[ISI][Medline]
DeAngelis, L.M. (1990) Primary central nervous system lymphoma imitates multiple sclerosis (1990). J. Neurooncol. 9,177 -181.[CrossRef][Medline]
DeAngelis, L.M. (1999) Primary central nervous system
lymphoma. J. Neurol. Neurosurg. Psychiatry
66,699
-701.
Donnelly, L.F., Frush, D.R., Marshall, K.W., and White, K.S.
(1998) Lymphoproliferative disorders: CT findings in
immunocompromised children. AJR. Am. J. Roentgenol.
171,725
-731.
Faro, A., Kurland, G., Michaels, M.G., Dickman, P.S., Greally, P.G., Spichty, K.J., Noyes, B.B., Boas, S.R., Fricker, F.J., Armitage, J.M., and Zeevi, A. (1996) Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. Am. J. Respir. Crit. Care Med. 153,1442 -1447.[Abstract]
Fukui, M.B., Livstone, B.J., Meltzer, C.C., and Hamilton, R.L. (1998) Hemorrhagic presentation of untreated primary CNS lymphoma in a patient with AIDS. AJR. Am. J. Roentgenol. 170,1114 -1115.[ISI][Medline]
Hanto, D.W., Frizzera, G., Gajl-Peczalska, K.J., and Simmons, R.L. (1985) Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 39,461 -472.[ISI][Medline]
Hardwidge, C., Diengdoh, J.V., Husband, D., and Nash, J.R. (1990) Primary cerebral lymphoma—a clinico-pathological study. Clin. Neuropathol. 9, 217-223.[ISI][Medline]
Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.,
Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C.,
Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink,
H.-K., Pileri, S.A., Piris, M.A., Ralfkiaer, E., and Warnke, R.A.
(1994) A revised European-American classification of lymphoid
neoplasms: A proposal from the International Lymphoma Study Group.
Blood 84,1361
-1392.
Jack, C.R., Jr., Reese, D.F., and Scheithauer, B.W.
(1986) Radiographicfindings in 32 cases of primary CNS lymphoma.
AJR. Am. J. Roentgenol.
146,271
-276.
Johnson, B.A., Fram, E.K., Johnson, P.C., and Jacobowitz, R. (1997) The variable MR appearance of primary lymphoma of the central nervous system: Comparison with histopathologic features. AJNR Am. J. Neuroradiol. 18,563 -572.[Abstract]
Kothbauer, P., Jellinger, K., and Falment, H. (1979) Primary brain tumour presenting as spontaneous intracerebral haemorrhage. Acta Neurochir. (Wein) 49, 35-45.
Krikorian, J.G., Anderson, J.L., Bieber, C.P., Penn, I., and Stinson, E.B. (1978) Malignant neoplasms following cardiac transplantation. JAMA 240,639 -643.[Abstract]
Kurtin, P.J., Hobday, K.S., Ziesmer, S., and Caron, B.L. (1999) Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am. J. Clin. Pathol. 112,319 -329.[ISI][Medline]
Kwan, J.T., Cotter, F.E., Pollock, L.E., Altmann, P., Lord, R.H.,
Raftery, M.J., and Cunningham, J. (1992) EBV-genome positive
monoclonal B cell cerebral lymphoma in a renal allograft recipient following
OKT3 therapy. Nephrol. Dial. Transplant.
7, 360-361.
Matas, A.J., Hertel, B.F., Rosai, J., Simmons, R.L., and Najarian, J.S. (1976) Post-transplant malignant lymphoma: Distinctive morphologic features related to its pathogenesis. Am. J. Med. 61,716 -720.[CrossRef][ISI][Medline]
McGiffin, D.C., Kirklin, J.K., Naftel, D.C., and Bourge, R.C. (1997) Competing outcomes after heart transplantation: A comparison of eras and outcomes. Heart Lung Transplant. 16,190 -198.[ISI][Medline]
Miller, W.T., Jr., Siegel, S.G., and Montone, K.T. (1997) Posttransplantation lymphoproliferative disorder: Changing manifestations of disease in a renal transplant population. Crit. Rev. Diagn. Imaging 38,569 -585.[ISI][Medline]
Molnar, P.P., O'Neill, B.P., Scheithauer, B.W., and Groothuis, D.R. (1999) The blood-brain barrier in primary CNS lymphomas: Ultrastructural evidence of endothelial cell death. Neuro-Oncology [serial online], Doc. 98-09, April 30, 1999. URL <neuro-oncology.mc.duke.edu>. J. Neurooncol. 1,89 -100.[CrossRef]
Morrison, V.A., Dunn, D.L., Manivel, J.C., Gajl-Peczalska, K.J., and Peterson, B.A. (1994) Clinical characteristics of post-transplant lymphoproliferative disorders. Am. J. Med. 97,14 -24.[ISI][Medline]
Murray, K., Kun, L., and Cox, J. (1986) Primary malignant lymphoma of the central nervous system: Results of treatment of 11 cases and review of the literature. J. Neurosurgery 65:600 -607.[ISI][Medline]
Myers, J.L., Kurtin, P.J., Katzenstein, A.L., Tazelaar, H.D., Colby, T.V., Strickler, J.G., Lloyd, R.V., and Isaacson, P.G. (1995) Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am. J. Surg. Pathol. 19,1300 -1312.[ISI][Medline]
Nalesnik, M.A., Jaffe, R., Starzl, T.E., Demetris, A.J., Porter, K., Burnham, J.A., Makowka, L., Ho, M., and Locker, J. (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am. J. Pathol. 133,173 -192.[Abstract]
O'Neill, B.P., and Illig, J. (1989) Primary central nervous system lymphoma. Mayo Clin. Proc. 64,1005 -1020.[ISI][Medline]
O'Neill, B.P., Kelly, P.J., Earle, J.D., Scheithauer, B., and
Banks, P.M. (1987) Computer-assisted stereotaxic biopsy for the
diagnosis of primary central nervous system lymphoma.
Neurology 37,1160
-1164.
Penn, I., and Starzl, T.E. (1972a) A summary of the status of de novo cancer in transplant recipients. Transplant. Proc. 4,719 -732.[ISI][Medline]
Penn, I., and Starzl, T.E. (1972b) Malignant tumors arising de novo in immuno-suppressed organ transplant recipients. Transplantation 14,407 -417.[ISI][Medline]
Penn, I., Hammond, W., Brettschneider, L., and Starzl, T.E. (1969) Malignant lymphomas in transplantation patients. Transplant. Proc. 1,106 -112.[ISI][Medline]
Poussaint, T.Y., Siffert, J., Barnes, P.D., Pomeroy, S.L., Goumnerova, L.C., Anthony, D.C., Sallan, S.E., and Tarbell, N. (1995) Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: Diagnosis and follow-up. AJNR Am. J. Neuroradiol. 16,693 -699.[Abstract]
Raab-Traub, N., and Flynn, K. (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47,883 -889.[CrossRef][ISI][Medline]
Roman-Goldstein, S.M., Goldman, D.L., Howieson, J., Belkin, R., and Neuwelt, E.A. (1992) MR of primary CNS lymphoma in immunologically normal patients. AJNR Am. J. Neuroradiol. 13,1207 -1213.[Abstract]
Schneck, S.A., and Penn, I. (1970) Cerebral neoplasms associated with renal transplantation. Arch. Neurol. 22:226 -233.[ISI][Medline]
Schneck, S.A., and Penn, I. (1971) De-novo brain tumours in renal-transplant recipients. Lancet 1, 983-986.[ISI][Medline]
Schwaighofer, B.W., Hesselink, J.R., Press, G.A., Wolf, R.L., Healy, M.E., and Berthoty, D.P. (1989) Primary intracranial CNS lymphoma: MR manifestations. AJNR Am. J. Neuroradiol. 10,725 -729.[Abstract]
Schwechheimer, K., Braus, D.F., Schwarzkopf, G., Feller, A.C., Volk, B., and Muller-Hermelink, H.K. (1994) Polymorphous high-grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas: Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies. Am. J. Surg. Pathol. 18,931 -937.[ISI][Medline]
Sherman, M.E., Erozan, Y.S., Mann, R.B., Kumar, A.A., McArthur, J.C., Royal, W., Uematsu S., and Nauta, H. (1991) Stereotactic brain biopsy in the diagnosis of malignant lymphoma. Am. J. Clin. Pathol. 95,878 -883.[ISI][Medline]
Southern, E.M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. Mol. Biol. 98,503 -517.[CrossRef]
Tomlinson, F.H., Kurtin, P.J., Suman, V.J., Scheithauer, B.W., O'Fallon, J.R., Kelly, P.J., Jack, C.R., Jr., and O'Neill, B.P. (1995) Primary intracerebral malignant lymphoma: A clinicopathological study of 89 patients. Neurosurgery 82,558 -566.
Tubman, D.E., Frick, M.P., and Hanto, D.W. (1983)
Lymphoma after organ transplantation: Radiologic manifestations in the central
nervous system, thorax, and abdomen. Radiology
149,625
-631.
van Diemen-Steenvoorde, R., Donckerwolcke, R.A., Kluin, P.M., Kapsenberg, J.G., Lepoutre, J.M., Fleer, A., Kuis, W., and Stoop, J.W. (1986) Epstein-Barr virus related central nervous system lymphoma in a child after renal transplantation. Int. J. Pediatr. Nephrol. 7,55 -58.[ISI][Medline]
Walker, R.C., Marshall, W.F., Strickler, J.G., Wiesner, R.H., Velosa, J.A., Habermann, T.M., McGregor, C.G., and Paya, C.V. (1995) Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin. Infect. Dis. 20,1346 -1353.[ISI][Medline]
Weintraub, J., and Warnke, R.A. (1982) Lymphoma in cardiac allotransplant recipients: Clinical and histological features and immunological phenotype. Transplantation 33,347 -351.[ISI][Medline]
Wood, A., Angus, B., Kestevan, P., Dark, J., Notarianni, G., Miller, S., Howard, M., Proctor, S., and Middleton, P. (1997) Alpha interferon gene deletions in post-transplant lymphoma. Br. J. Haematol. 98,1002 -1003.[CrossRef][ISI][Medline]
Zimmerman, R.A., and Bilaniuk, L.T. (1980) Computed
tomography of acute intratumoral hemorrhage. Radiology
135,355
-359.
This article has been cited by other articles:
|
|
 |
|
  B. P. O'Neill, S. Vernino, A. Dogan, and C. Giannini EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil Neuro-oncol, July 1, 2007; 9(3): 364 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Besenski, Z. Rumboldt, O. Emovon, J. Nicholas, S. Kini, J. Milutinovic, and M. N. Budisavljevic Brain MR Imaging Abnormalities in Kidney Transplant Recipients AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2282 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino, D. R. Salomao, T. M. Habermann, and B. P. O'Neill Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil Neurology, August 23, 2005; 65(4): 639 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lai, M. K. Rosenblum, and L. M. DeAngelis Primary CNS lymphoma: A whole-brain disease? Neurology, November 26, 2002; 59(10): 1557 - 1562. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
